Actinium Pharmaceuticals, Inc. 4
4 · Actinium Pharmaceuticals, Inc. · Filed Mar 16, 2015
Insider Transaction Report
Form 4
DAVE KAUSHIK J
DirectorPresident and CEO
Transactions
- Award
Options to purchase common stock
2015-02-18$3.58/sh+150,000$537,000→ 150,000 totalExercise: $3.58Exp: 2025-02-18→ Common stock (150,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant.